Leading healthcare products maker Covidien plc (NYSE:COV - News) recently secured approval of the U.S. Food and Drug Administration’s (“FDA”) for its embolic protection device dubbed SpiderFX.
Covidien's SpiderFX is the only embolic protection device in the U.S. indicated for use in the lower extremities. (Photo: Business Wire) Embolic protection devices are used to capture and remove ...
Covidien (NYSE: COV) announced this morning it has received clearance from the FDA to market SpiderFX, an embolic protection device designed to prevent complications during interventional procedures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback